Innovative Nanoparticles Enhance N-Palmitoylethanolamide Intraocular Delivery.

about

Innovative Nanoparticles Enhance N-Palmitoylethanolamide Intraocular Delivery.

Item

http://www.wikidata.org/entity/Q52592946

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Innovative Nanoparticles Enhance N-Palmitoylethanolamide Intraocular Delivery.

@en

Innovative Nanoparticles Enhance N-Palmitoylethanolamide Intraocular Delivery.

@nl

type

Item

label

Innovative Nanoparticles Enhance N-Palmitoylethanolamide Intraocular Delivery.

@en

Innovative Nanoparticles Enhance N-Palmitoylethanolamide Intraocular Delivery.

@nl

prefLabel

Innovative Nanoparticles Enhance N-Palmitoylethanolamide Intraocular Delivery.

@en

Innovative Nanoparticles Enhance N-Palmitoylethanolamide Intraocular Delivery.

@nl

P1476

Innovative Nanoparticles Enhance N-Palmitoylethanolamide Intraocular Delivery

@en

P2093

Barbara Albertini

http://www.w3.org/2001/XMLSchema#string

Carmine Ostacolo

http://www.w3.org/2001/XMLSchema#string

Chiara B M Platania

http://www.w3.org/2001/XMLSchema#string

Eduardo Sommella

http://www.w3.org/2001/XMLSchema#string

Federica Geraci

http://www.w3.org/2001/XMLSchema#string

Filippo Drago

http://www.w3.org/2001/XMLSchema#string

Giovanni L Romano

http://www.w3.org/2001/XMLSchema#string

Giovanni Puglisi

http://www.w3.org/2001/XMLSchema#string

Pietro Campiglia

http://www.w3.org/2001/XMLSchema#string

Rosario Pignatello

http://www.w3.org/2001/XMLSchema#string

P2860

Nanostructured lipid carrier (NLC) coated with Chitosan Oligosaccharides and its potential use in ocular drug delivery system.

The nuclear receptor peroxisome proliferator-activated receptor-alpha mediates the anti-inflammatory actions of palmitoylethanolamide.

N-palmitoyl-ethanolamine: Biochemistry and new therapeutic opportunities.

Ocular hypotensive effect of oral palmitoyl-ethanolamide: a clinical trial.

Effect of palmitoylethanolamide on visual field damage progression in normal tension glaucoma patients: results of an open-label six-month follow-up.

Rapid broad-spectrum analgesia through activation of peroxisome proliferator-activated receptor-alpha.

Topical Ocular Drug Delivery to the Back of the Eye by Mucus-Penetrating Particles.

Palmitoylethanolamide Modulates Inflammation-Associated Vascular Endothelial Growth Factor (VEGF) Signaling via the Akt/mTOR Pathway in a Selective Peroxisome Proliferator-Activated Receptor Alpha (PPAR-α)-Dependent Manner.

PLGA nanoparticles in drug delivery: the state of the art.

Current and future ophthalmic drug delivery systems. A shift to the posterior segment.

P304

285

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3389/FPHAR.2018.00285

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2018-03-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29643808

http://www.w3.org/2001/XMLSchema#string

P932

5882782

http://www.w3.org/2001/XMLSchema#string